Amman-Mubasher: The Jordanian Pharmaceutical Manufacturing (JPM) reported a surge in losses by 233% to JOD 5.9 million ($8.3 million) in 2014, compared to JOD 1.77 million ($2.49 million).
The company’s H1-14 losses rose 40.17% to JOD 5.7 million, compared to JOD 4.08 million in H1-13.
JPM’s capital amounts to JOD 40 million, distributed on 40 million shares at JOD 1 par value each.